ReproCell Inc
TSE:4978
ReproCell Inc
TSE:4978
Price:
133 JPY
-2.21%
Market Closed
Updated:
May 15, 2024
ReproCell Inc
Income from Continuing Operations
|
ReproCell Inc
Income from Continuing Operations Peer Comparison
Comparables:
2160
4587
4974
2929
S
4599
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ReproCell Inc
TSE:4978
|
Income from Continuing Operations
-¥217.5m
|
CAGR 3-Years
40%
|
CAGR 5-Years
36%
|
CAGR 10-Years
-16%
|
|
|
GNI Group Ltd
TSE:2160
|
Income from Continuing Operations
¥9.5B
|
CAGR 3-Years
91%
|
CAGR 5-Years
118%
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Income from Continuing Operations
¥3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Income from Continuing Operations
¥1.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
2%
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Income from Continuing Operations
¥4.8B
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
40%
|
|
S
|
StemRIM Inc
TSE:4599
|
Income from Continuing Operations
¥168.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ReproCell Inc's Income from Continuing Operations?
Income from Continuing Operations
-217.5m
JPY
-217.5m
JPY
Based on the financial report for Dec 31, 2023, ReproCell Inc's Income from Continuing Operations amounts to -217.5m JPY.
What is ReproCell Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-16%
-16%
Over the last year, the Income from Continuing Operations growth was 17%. The average annual Income from Continuing Operations growth rates for ReproCell Inc have been 40% over the past three years , 36% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
